These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 9600381)
1. Genomic difference analysis by two-dimensional DNA fingerprinting reveals typical changes in human low-grade gliomas. Marczinek K; Hampe J; Uhlmann K; Thiel G; Barth I; Mrowka R; Vogel S; Nürnberg P Glia; 1998 Jun; 23(2):130-8. PubMed ID: 9600381 [TBL] [Abstract][Full Text] [Related]
2. Parallel genome analysis by one- and two-dimensional DNA fingerprinting in human gliomas. Nürnberg P; Marczinek K; Thiel G; Hampe J Electrophoresis; 1995 Sep; 16(9):1715-25. PubMed ID: 8582361 [TBL] [Abstract][Full Text] [Related]
3. Cloning of minisatellite-containing sequences from two-dimensional DNA fingerprinting gels reveals the identity of genomic alterations in low-grade gliomas of different patients. Marczinek K; Sugiyama A; Hampe J; Thiel G; Lehmann K; Neumann R; de Leeuw WJ; Nürnberg P Electrophoresis; 1997 Aug; 18(9):1586-91. PubMed ID: 9378126 [TBL] [Abstract][Full Text] [Related]
4. Karyotypes in 90 human gliomas. Thiel G; Losanowa T; Kintzel D; Nisch G; Martin H; Vorpahl K; Witkowski R Cancer Genet Cytogenet; 1992 Feb; 58(2):109-20. PubMed ID: 1551072 [TBL] [Abstract][Full Text] [Related]
5. Changes in methylation patterns identified by two-dimensional DNA fingerprinting. Uhlmann K; Marczinek K; Hampe J; Thiel G; Nürnberg P Electrophoresis; 1999 Jun; 20(8):1748-55. PubMed ID: 10435443 [TBL] [Abstract][Full Text] [Related]
7. Molecular genetic evidence for subtypes of oligoastrocytomas. Maintz D; Fiedler K; Koopmann J; Rollbrocker B; Nechev S; Lenartz D; Stangl AP; Louis DN; Schramm J; Wiestler OD; von Deimling A J Neuropathol Exp Neurol; 1997 Oct; 56(10):1098-104. PubMed ID: 9329453 [TBL] [Abstract][Full Text] [Related]
8. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene. Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179 [TBL] [Abstract][Full Text] [Related]
9. Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas. von Deimling A; Louis DN; von Ammon K; Petersen I; Wiestler OD; Seizinger BR Cancer Res; 1992 Aug; 52(15):4277-9. PubMed ID: 1353411 [TBL] [Abstract][Full Text] [Related]
10. Coamplification of simple repetitive DNA fingerprint fragments and the EGFR gene in human gliomas. Nürnberg P; Zischler H; Fuhrmann E; Thiel G; Losanova T; Kinzel D; Nisch G; Witkowski R; Epplen JT Genes Chromosomes Cancer; 1991 Mar; 3(2):79-88. PubMed ID: 1676908 [TBL] [Abstract][Full Text] [Related]
11. Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and nonrandom chromosomal gains and losses. Schröck E; Thiel G; Lozanova T; du Manoir S; Meffert MC; Jauch A; Speicher MR; Nürnberg P; Vogel S; Jänisch W Am J Pathol; 1994 Jun; 144(6):1203-18. PubMed ID: 8203461 [TBL] [Abstract][Full Text] [Related]
13. Cytogenetic and loss of heterozygosity studies in ependymomas, pilocytic astrocytomas, and oligodendrogliomas. Ransom DT; Ritland SR; Kimmel DW; Moertel CA; Dahl RJ; Scheithauer BW; Kelly PJ; Jenkins RB Genes Chromosomes Cancer; 1992 Nov; 5(4):348-56. PubMed ID: 1283324 [TBL] [Abstract][Full Text] [Related]
14. Cytogenetic analysis of gemistocytic cells in gliomas. Kros JM; Waarsenburg N; Hayes DP; Hop WC; van Dekken H J Neuropathol Exp Neurol; 2000 Aug; 59(8):679-86. PubMed ID: 10952058 [TBL] [Abstract][Full Text] [Related]
15. A cytogenetic study of 53 human gliomas. Jenkins RB; Kimmel DW; Moertel CA; Schultz CG; Scheithauer BW; Kelly PJ; Dewald GW Cancer Genet Cytogenet; 1989 Jun; 39(2):253-79. PubMed ID: 2752377 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of a potential epigenetic biomarker by quantitative methyl-single nucleotide polymorphism analysis. Uhlmann K; Brinckmann A; Toliat MR; Ritter H; Nürnberg P Electrophoresis; 2002 Dec; 23(24):4072-9. PubMed ID: 12481262 [TBL] [Abstract][Full Text] [Related]
17. Molecular fingerprinting reflects different histotypes and brain region in low grade gliomas. Mascelli S; Barla A; Raso A; Mosci S; Nozza P; Biassoni R; Morana G; Huber M; Mircean C; Fasulo D; Noy K; Wittemberg G; Pignatelli S; Piatelli G; Cama A; Garré ML; Capra V; Verri A BMC Cancer; 2013 Aug; 13():387. PubMed ID: 23947815 [TBL] [Abstract][Full Text] [Related]
18. Correlation of cytogenetic analysis and loss of heterozygosity studies in human diffuse astrocytomas and mixed oligo-astrocytomas. Ransom DT; Ritland SR; Moertel CA; Dahl RJ; O'Fallon JR; Scheithauer BW; Kimmel DW; Kelly PJ; Olopade OI; Diaz MO Genes Chromosomes Cancer; 1992 Nov; 5(4):357-74. PubMed ID: 1283325 [TBL] [Abstract][Full Text] [Related]
19. Gains and losses of DNA sequences in childhood brain tumors analyzed by comparative genomic hybridization. Shlomit R; Ayala AG; Michal D; Ninett A; Frida S; Boleslaw G; Gad B; Gideon R; Shlomi C Cancer Genet Cytogenet; 2000 Aug; 121(1):67-72. PubMed ID: 10958944 [TBL] [Abstract][Full Text] [Related]
20. Paediatric high and low grade glioma: the impact of tumour biology on current and future therapy. Hargrave D Br J Neurosurg; 2009 Aug; 23(4):351-63. PubMed ID: 19637006 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]